🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials in this register

19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC
NCT06998719Non-small Cell Lung Cancer Stage III, Borderline Resectable Carcinoma
Bi Nan
Phase 2
80
Beijing
2025-07
Not yet open
A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma
NCT07062484Lung Metastatic Nasopharyngeal Carcinoma
Sichuan Cancer Hospital and Research Institute
Not applicable
600
Chengdu
2025-07
Not yet open
Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
NCT07079410Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma, Resectable Oral and Oropharyngeal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase 2
50
Shanghai
2025-07
Not yet open
Surgery for Relapsed Ovarian Cancer in Precision
NCT06602063Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group
Phase 1/2
33
Shanghai, Wuhan
2025-07
Not yet open
Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)
NCT07032532Peripheral T Cell Lymphoma
Sun Yat-sen University
Phase 2
35
Guanzhou
2025-07
Not yet open
A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China
NCT07042113Atopic Dermatitis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 1
180
Wenzhou, Shanghai
2025-07
Recruiting
JY231(JY231) Injection for the Treatment of R/R B-cell Malignancies
NCT07065279B-cell Malignancies
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Not applicable
36
Kunming
2025-07
Not yet open
A Study of QLS5133 Monotherapy in Advanced Solid Tumors
NCT07061639Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2
212
Shanghai
2025-07
Not yet open
Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer
NCT07041437Advanced Breast Cancer
Fudan University
Phase 2
48
Shanghai
2025-06-30
Not yet open
Efficacy of the Ranger Drug-Coated Balloon in Treating BTK Lesions in Patients With CLTI
NCT07014475Chronic Limb Threatening Ischemia
First Affiliated Hospital, Sun Yat-Sen University
Observational
700
Guangzhou
2025-06-30
Not yet open
PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer
NCT07031011Advanced Gastric or Colorectal Cancer
jiuwei cui
Phase 1
22
Changchun
2025-06-30
Not yet open
A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer
NCT07031154Non-Small Cell Lung Cancer, Adebrelimab, Apatinib
The First Affiliated Hospital of Xiamen University
Phase 2
43
Xiamen
2025-06-30
Active, closed
A Study on Bioequivalence of Cabergoline Tablets in Human Body
NCT07008417Hyperprolactinemia
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
72
Hangzhou
2025-06-30
Recruiting
Comparison of Different Pulsed Field Ablation Catheters in Atrial Fibrillation
NCT07036965Atrial Fibrillation (AF)
Hangzhou Dinova EP Technology Co., Ltd
Not applicable
292
Hangzhou
2025-06-30
Recruiting
A Random, Non-controlled, Open Clinical Study of Apatinib Mesylate Combined With Albumin-bound Paclitaxel ± Adebrelimab in Treating Advanced Second-line Gastric Cancer
NCT07770113GC/GEJC
The First Affiliated Hospital of Zhengzhou University
Phase 2
50
Zhengzhou
2025-06-30
Recruiting
Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease)
NCT07509749GVHD, Acute, Stem Cell Transplant Complications
Daihong Liu
Phase 2
54
Beijing
2025-06-30
Not yet open
Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer
NCT07005583Triple-Negative Breast Cancer (TNBC)
Tianjin Medical University Cancer Institute and Hospital
Phase 2
46
Tianjin
2025-06-30
Recruiting
A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Malignant Brain Tumors
NCT07003139Malignant Brain Tumors
China Medical University Hospital
Phase 1/2
10
2025-06-30
Recruiting
A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC
NCT06962865Non-Small Cell Lung Cancer
RemeGen Co., Ltd.
Phase 2
80
Beijing, Binzhou, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou
2025-06-30
By invitation
Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)
NCT07023965Peripheral Arterial Disease(PAD), Arterial Occlusive Disease, Arteriosclerosis Obliterans, Thromboangiitis Obliterans
Beijing Northland Biotech. Co., Ltd.
Observational
542
Beijing, Chifeng, Dalian, Hangzhou, Xi'an
2025-06-30
Recruiting
FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma
NCT07058428Multiple Brain Metastases in Lung Adenocarcinoma
Sun Yat-Sen University Cancer Center
Phase 3
258
Guangzhou
2025-06-30
By invitation
Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants
NCT07182552TED
Nanjing Chia-tai Tianqing Pharmaceutical
Phase 1
40
Beijing
2025-06-30
Recruiting
Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer
NCT07116213Endometrial Cancer, Hypofractionated Dose, Radiotherapy, Adjuvant, Side Effects
Xiaorong Hou
Not applicable
20
Beijing
2025-06-30
Recruiting
Effectiveness of DITM Versus IMT in COPD Patients
NCT06958666COPD (Chronic Obstructive Pulmonary Disease)
Sir Run Run Shaw Hospital
Not applicable
410
Hangzhou, Lishui, Taizhou
2025-06-30
Not yet open
PCT Guided Antibiotics Use in Critically Ill Adult Patients in China
NCT06945510Sepsis
China-Japan Friendship Hospital
Not applicable
800
Beijing
2025-06-30
Not yet open
Efficacy and Safety of Plasma Adsorption Combined With EVT for AIS-LVO
NCT07042490Acute Ischemic Stroke From Large Vessel Occlusion, Endovascular Thrombectomy
Yi Yang
Not applicable
100
Changchun
2025-06-30
Recruiting
A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors
NCT07071090Solid Tumor Malignancies
Heronova Pharmaceuticals
Phase 1
32
Fuzhou, Guangzhou, Nanning, Harbin, Zhengzhou, Changsha, Jinan, Hangzhou
2025-06-30
Recruiting
Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision
NCT07651553Rectal Cancer Patients, Robotic Assisted Intervention
Sun Yat-sen University
Not applicable
216
Guangzhou
2025-06-30
Not yet open
Enteral Nutrition With L-Carnitine for Cachexia in Non-Small Cell Lung Cancer
NCT07035444Non-Small Cell Lung Cancer, Cachexia
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Not applicable
126
Chongqing
2025-06-30
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC
Phase 3
2,400
Hefei, Beijing, Xiamen, Guangzhou, Jiangmen, Liuzhou, Nanning, Xingtai
2025-06-30
Recruiting
Study on the Trans-Carotid Artery Occlusion Shunt System
NCT06924593Revascularization, Carotid Artery Stenosis, Carotid Artery Diseases
Shenzhen Wecan Medical Technology Co.,Ltd
Not applicable
162
Beijing
2025-06-30
Not yet open
Bioabsorbable Occluder for Outlet VSD: Safety and Aortic Valve Effects
NCT07040579Congenital Heart Defects, VSD
First Affiliated Hospital of Guangxi Medical University
Observational
50
Nanning
2025-06-30
By invitation
Extubation Safety Via Microstream EtCO₂ (IPI) Monitoring
NCT06975553Hypoxemia
Chinese PLA General Hospital
Not applicable
632
Beijing
2025-06-30
Not yet open
The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's Disease
NCT07028632Parkinson Disease (PD)
iRegene Therapeutics Co., Ltd.
Phase 2
30
Beijing
2025-06-30
Not yet open
FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade Glioma Patients With BRAF Alteration
NCT07004075Low-grade Glioma, Pediatric Low-grade Gliomas, pLGG With BRAF Alteration
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 3
102
Beijing
2025-06-30
Recruiting
Modifiable Risk Factors for Cognitive Dysfunction in Patients With Coronary Heart Disease
NCT07657624Coronary Heart Disease, Cognitive Impairment, Mild
Beijing Anzhen Hospital
Observational
2,352
Beijing
2025-06-30
By invitation
A Study on the Efficacy of Environmental Probiotics in Patients With Cat Hair Allergies
NCT07114133Cat Allergy (Disorder), Allergic Rhinitis, Allergic Asthma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
100
Hangzhou
2025-06-30
Recruiting
Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy
NCT07012304Chronic Graft Versus Host Disease
Yujun DONG
Phase 1/2
24
Beijing
2025-06-30
Not yet open
Daoyin Technique for Improving Exercise Endurance in IPF
NCT07019714Idiopathic Pulmonary Fibrosis
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Not applicable
236
Shenyang
2025-06-30
Active, closed
Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation
NCT07034950Hepatic Neoplasm, Hepatic Cancer
The First Affiliated Hospital of Xiamen University
Phase 1/2
79
Xiamen
2025-06-29
Recruiting
Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial
NCT07003620Cervical Cancers
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
34
Guangzhou
2025-06-29
Recruiting
Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis
NCT07079423AL Amyloidosis
Peking Union Medical College Hospital
Phase 2
35
Beijing
2025-06-28
Recruiting
Dalpiciclib Combined With Aromatase Inhibitors and Olmesartan as the First-line Treatment for HR+/HER2- Advanced Breast Cancer
NCT07810088HR+ / HER2- Advanced Breast Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
40
Wuhan
2025-06-28
Recruiting
A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)
NCT07039201Advanced Hepatocellular Carcinoma (HCC)
Zhejiang University
Not applicable
12
Hangzhou
2025-06-28
Recruiting
CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies
NCT07106749Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 1
12
Tianjin
2025-06-28
Recruiting
SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies
NCT07153068T Lymphoblastic Leukemia/Lymphoma, Acute Myeloid Leukemia (AML)
Institute of Hematology & Blood Diseases Hospital, China
Phase 1/2
12
Tianjin
2025-06-28
Recruiting
Randomised Controlled Trial of Artificial Intelligence-assisted Health Education
NCT07305337Leukaemia, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Lymphoma
Zhongnan Hospital
Not applicable
196
Wuhan
2025-06-28
Recruiting
Development, Application, and Mechanistic Investigation of a Novel Minimally-Invasive Bidirectional Epidural Cerebellar Stimulation Technique for Cerebellar Cognitive Affective Syndrome
NCT07166432Cerebellar Atrophy, Etiology, Physiopathology
Peking University First Hospital
Observational
200
Beijing
2025-06-28
Recruiting
Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study
NCT07169487Cytokine Release Syndrome, ICANS
Institute of Hematology & Blood Diseases Hospital, China
Phase 1
18
Tianjin
2025-06-28
Recruiting
Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells
NCT07041801Systemic Lupus Erythematosus (SLE)
Shenzhen Beike Bio-Technology Co., Ltd.
Phase 1/2
58
Shenzhen
2025-06-28
Recruiting
Effect of MGRNOX-Guided General Anesthesia on Opioid Consumption in Patients
NCT07004686Opioid Use
Peking University Shenzhen Hospital
Not applicable
112
Shenzhen
2025-06-28
By invitation
Explainable Machine Learning for Predicting Early Gastric Cancer
NCT07047937Early Gastric Cancer
Wenzhou Central Hospital
Observational
10
Wenzhou
2025-06-28
Recruiting
uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies
NCT07109518Acute Myeloid Leukemia (AML), T Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 1
12
Tianjin
2025-06-28
Active, closed
Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors
NCT07040969Radiation-induced Oral Mucositis
West China Hospital
Phase 2
70
Chengdu
2025-06-27
Recruiting
PH-DyPred: A Multimodal Dynamic Risk Prediction Study in Pulmonary Hypertension
NCT07131241Pulmonary Hypertension
First Affiliated Hospital of Fujian Medical University
Observational
1,000
Fuzhou
2025-06-27
Recruiting
Evaluating the Efficacy and Safety of Contact Lens Lubricant in Rigid Gas Permeable Corneal Contact Lens Wearers
NCT07091825Myopia
Avizor SA
Not applicable
152
Beijing, Tianjin
2025-06-27
Recruiting
A Phase I Study of SNH-119014 in Healthy Volunteers
NCT07087262Hemoglobinopathy
ScinnoHub Pharmaceutical Co., Ltd.
Phase 1
96
Hefei
2025-06-27
Recruiting
A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®
NCT07062978Postmenopausal Women With Osteoporosis at High Risk of Fracture
Qilu Pharmaceutical Co., Ltd.
Phase 3
278
Guizhou
2025-06-27
Recruiting
Early Feasibility Study of Surgical Implantation of a Polymer Prosthetic Mitral and Aortic Valve
NCT07097740AORTIC VALVE DISEASES, Mitral Valve Disease, Aortic Stenosis, Aortic Regurgitation
Mitrassist Lifesciences Limited Co., Ltd.
Not applicable
10
Shanghai
2025-06-27
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
NCT07082738Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca
Phase 2
987
Baotou, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou
2025-06-27
Recruiting
A Retrospective Analysis of Robot-Assisted Versus Endoscopic Breast-Conserving Surgery for Breast Cancer
NCT07321145Breast Cancer, Breast Surgery
Sixth Affiliated Hospital, Sun Yat-sen University
Not applicable
200
Guangzhou
2025-06-27
Recruiting
Prospective Single-Arm Clinical Trial of GO Regimen for HLH.
NCT07339345Lymphohistiocytosis, Hemophagocytic
Beijing Friendship Hospital
Phase 2/3
28
Beijing
2025-06-27
Recruiting
Study of CM518D1 in Patients With Advanced Solid Tumors
NCT07019779Advanced Solid Tumors
Keymed Biosciences Co.Ltd
Phase 1/2
434
Guangzhou
2025-06-27
Not yet open
QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC
NCT07009145Unresectable Colorectal Cancer, Metastatic Colorectal Cancer (CRC), MSI-H/dMMR Colorectal Cancer
Qianfoshan Hospital
Phase 2
22
Jinan
2025-06-27
Recruiting
BM Shockwave Devices Clinical Study in Coronary Calcified Lesions
NCT07010094Coronary Artery Disease
BrosMed Medical Co., Ltd
Not applicable
198
Fujian
2025-06-27
Recruiting
Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
NCT07067905Clear Cell Renal Cell Carcinoma and Glioblastoma
Chinese PLA General Hospital
Phase EARLY_PHASE1
15
Beijing
2025-06-27
Recruiting
Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) in Breast Cancer Patients
NCT07096869Bioequivalence
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase 1
28
Changchun
2025-06-26
Recruiting
Evidence-based Practice in the Management of Gastric Tube Placement in Children
NCT07038538Hospitalized Children, Nursing, Enteral Nutrition Therapy
Children's Hospital of Fudan University
Not applicable
2,750
Shanghai, Beijing, Chongqing, Gansu, Guangdong, Hefei, Henan, Hunan
2025-06-26
Active, closed
A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
NCT06973304Short Bowel Syndrome
Takeda
Phase 3
13
Changping, Dongcheng, Nanjing, Siming
2025-06-26
Recruiting
A Phase I Study of HW201877 in Healthy Subjects
NCT07373457Healthy Participants, IBD (Inflammatory Bowel Disease)
Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
Phase 1
104
Changchun
2025-06-26
Recruiting
Efficacy and Safety of Attapulgite in Patients With Obesity: An Exploratory Clinical Trial
NCT07103382Obesity
Second Xiangya Hospital of Central South University
Not applicable
40
Changsha
2025-06-26
Active, closed
Study on the Effective Dose and Safety of Esketamine in Hysteroscopic Surgery Under Monitored Anesthesia Care
NCT07034963Intrauterine Polyp, Intrauterine Synechiae
The First Affiliated Hospital of Xiamen University
Phase 1/2
95
Xiamen
2025-06-26
Recruiting
Hybrid Closed-Loop for Perioperative Glycemic Control in T2DM With Parenteral Nutrition
NCT07121504Type 2 Diabetes
Second Xiangya Hospital of Central South University
Not applicable
40
Changsha
2025-06-26
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
Amgen
Phase 3
5,056
Hefei, Beijing, Guangzhou, Haikou, Qinhuangdao, Shijiazhuang, Harbin, Kaifeng
2025-06-25
Recruiting
Dexamethasone Palmitate for PONV After Craniotomy
NCT06988124Postoperative Nausea and Vomiting
Beijing Tiantan Hospital
Not applicable
500
Beijing
2025-06-25
Active, closed
Hyperkalemia Quality Improvement Program (HK-QIP) Study
NCT06884267Hyperkalemia
AstraZeneca
Not applicable
1,000
Beijing, Benxi, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuyang
2025-06-25
Recruiting
A Study of CT0596 in Plasma Cell Leukemia
NCT06988059Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase EARLY_PHASE1
27
Tianjin
2025-06-25
Recruiting
Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001
NCT07264569Meningeal Metastasis
Henan Cancer Hospital
Phase 1/2
42
Zhengzhou
2025-06-25
Recruiting
A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)
NCT07035626Radiation-induced Xerostomia
West China Hospital
Phase 1/2
58
Chengdu
2025-06-25
Active, closed
A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD
NCT06843408Chronic Graft-versus-host-disease
Incyte Corporation
Phase 1/2
32
Beijing, Chengdu, Chongoing, Guangzhou, Hangzhou, Shanghai, Tianjin, Wuhan
2025-06-25
Recruiting
An Efficacy and Safety Study of Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia
NCT06974266Hypercholesterolaemia
Moon (Guangzhou) Biotechnology Co., Ltd.
Not applicable
60
Zibo
2025-06-25
Not yet open
Fine-needle Biopsy Combined With Macroscopic On-site Evaluation for Diagnosis of Solid Pancreatic Lesions
NCT06994611Pancreatic Diseases
Changhai Hospital
Not applicable
148
Shanghai
2025-06-25
Recruiting
A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC
NCT06951464Non-Small Cell Lung Cancer
Sichuan University
Phase 2
40
Chengdu
2025-06-25
Not yet open
The 22G Trident Needle Combined With Different Aspiration Techniques for Endoscopic Ultrasound-guided Fine-needle Biopsy
NCT07023562Pancreatic Diseases
Changhai Hospital
Not applicable
270
Shanghai
2025-06-25
Recruiting
The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy
NCT07049094Brain Tumor Adult, Cerebrovascular Disease
Zhejiang University
Phase 4
218
Hangzhou
2025-06-25
By invitation
Study on the Efficacy of Non-invasive Spinal Cord Electrical Stimulation in Neuropathic Pain
NCT07046143Neuropathic Pain
Nanchang University Affiliated Rehabilitation Hospital
Not applicable
62
Nanchang
2025-06-25
Recruiting
Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib
NCT07033819Ovarian Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
48
Beijing
2025-06-25
Active, closed
Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma
NCT06673693Head and Neck Squamous Cell Carcinoma (HNSCC), HNSCC
Sun Yat-sen University
Phase 2
24
Guangzhou
2025-06-25
Recruiting
Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer
NCT07285382HR Positive HER2 Negative Advanced Breast Cancer
wanghaibo
Phase 2
120
Dalian, Qingdao
2025-06-25
Recruiting
Research on Binaural Synchronous Vagus Nerve Regulation of Sensorimotor Disorders After Cerebral Infarction
NCT07081568Cerebral Infarction
Nanchang University Affiliated Rehabilitation Hospital
Not applicable
40
Nanchang
2025-06-25
Recruiting
Phase I Study of MT1011 Injection in Healthy Subjects
NCT07024160Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation
Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Phase 1
40
Beijing
2025-06-25
Recruiting
A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors
NCT07028268For Prevention of Bone Events in Patients With Bone Metastases From Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
210
Guangzhou
2025-06-24
Recruiting
Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)
NCT06483737Overt Hepatic Encephalopathy
General Hospital of Shenyang Military Region
Not applicable
174
Shenyang
2025-06-24
Recruiting
A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening
NCT07032961Gastritis, Gastric Dysplasia, Gastric Ulcer, Gastric Cancer
Nanfang Hospital, Southern Medical University
Observational
10,000
Guangzhou
2025-06-24
Recruiting
Stellate Ganglion Morphine Infiltration on Myocardial I/R Injury
NCT07023679Acute Myocardial Infarction (AMI)
The Second Hospital of Anhui Medical University
Not applicable
2,588
Hefei
2025-06-24
Recruiting
Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia
NCT06922669Drug Induced Liver Injury
General Hospital of Shenyang Military Region
Not applicable
232
Shenyang
2025-06-24
Recruiting
Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer
NCT07057427Breast Cancer
Henan Cancer Hospital
Phase 3
812
Zhengzhou
2025-06-24
Recruiting
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial
NCT07070479Recurrent or Metastatic Nasopharyngeal Carcinoma
Ming-Yuan Chen
Phase 2
208
Guangzhou, Zhongshan, Zhuhai, Changsha
2025-06-24
Recruiting
A Study of BL-B01D1 Monotherapy, BL-B01D1 in Combination With Lenvatinib, BL-B01D1 in Combination With PD-1 Monoclonal Antibody, and BL-B01D1 in Combination With PD-1 Monoclonal Antibody and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma
NCT06986785Advanced Hepatocellular Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
74
Shanghai
2025-06-24
Not yet open
A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
NCT07036185Gastric/Gastroesophageal Junction Cancer, Breast Cancer, Colorectal Cancer, Non-small Cell Lung Cancer (NSCLC)
Shanghai Bao Pharmaceuticals Co., Ltd.
Phase 1
66
Shanghai
2025-06-24
Rows per page Showing 7401–7500 of 19052
Previous 73 74 75 76 77 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china?page=75

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,786 of the 19,052 studies in this register are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3,920 have not yet opened recruitment, 2,668 are active but closed to new participants, and 678 are enrolling by invitation only. Eligibility for any study is decided by its study team.

→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.